CytRx Corporation (NASDAQ: CYTR) unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE